Renaissance Technologies - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 3.89 and the average weighting 0.4%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,338
+9.2%
55,700
+31.4%
0.01%
+50.0%
Q2 2023$3,057
+39.5%
42,400
+42.3%
0.00%
+33.3%
Q1 2023$2,192
+33.9%
29,800
+21.6%
0.00%
+50.0%
Q4 2022$1,637
-99.9%
24,500
+46.7%
0.00%0.0%
Q3 2022$1,438,000
-10.4%
16,700
-7.2%
0.00%0.0%
Q2 2022$1,605,000
-89.4%
17,994
-86.7%
0.00%
-84.6%
Q2 2020$15,161,000
-65.2%
135,544
-77.4%
0.01%
-69.0%
Q1 2020$43,628,000
-59.0%
599,944
-41.3%
0.04%
-48.8%
Q4 2019$106,500,000
-12.3%
1,021,189
-16.3%
0.08%
-20.4%
Q3 2019$121,380,000
-17.0%
1,219,414
-4.8%
0.10%
-20.2%
Q2 2019$146,204,000
-17.8%
1,280,808
-9.5%
0.13%
-20.4%
Q1 2019$177,969,000
-11.4%
1,415,708
-4.4%
0.16%
-26.4%
Q4 2018$200,947,000
-2.9%
1,480,819
+96.3%
0.22%
+3.3%
Q3 2018$207,026,000
+22.8%
754,219
-15.1%
0.21%
+131.5%
Q2 2018$168,635,000
+180.2%
887,888
+143.7%
0.09%
+39.4%
Q1 2018$60,183,000
+789.8%
364,394
+637.6%
0.07%
+842.9%
Q4 2017$6,764,000
-28.7%
49,400
-36.7%
0.01%
-41.7%
Q2 2017$9,481,000
-11.4%
78,094
-22.8%
0.01%
-20.0%
Q1 2017$10,702,000
-22.7%
101,115
-12.8%
0.02%
-42.3%
Q2 2016$13,836,000
+10.6%
116,004
-0.7%
0.03%
+8.3%
Q1 2016$12,508,000
-33.8%
116,800
-33.0%
0.02%
-41.5%
Q4 2015$18,898,000
+205.6%
174,300
+141.4%
0.04%
+173.3%
Q3 2015$6,184,000
-36.2%
72,200
-24.9%
0.02%
-31.8%
Q2 2015$9,696,000
+303.3%
96,094
+149.0%
0.02%
+266.7%
Q2 2014$2,404,00038,5940.01%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Knott David M Jr 115,000$8,4593.32%
VILLERE ST DENIS J & CO LLC 480,807$35,368,1622.57%
Chicago Capital, LLC 449,508$33,065,8221.64%
RICE HALL JAMES & ASSOCIATES, LLC 288,345$21,210,6811.20%
Smith, Graham & Co., Investment Advisors, LP 65,163$4,793,3900.58%
Stephens Investment Management Group LLC 455,089$33,476,3470.56%
CARDINAL CAPITAL MANAGEMENT LLC /CT 201,993$14,858,6050.53%
WOODSTOCK CORP 52,604$3,869,5500.49%
Court Place Advisors, LLC 15,533$1,142,6070.41%
Jackson Creek Investment Advisors LLC 12,726$9360.39%
View complete list of LIGAND PHARMACEUTICALS INC shareholders